Colgate-Palmolive (India) Limited (COLPAL) Operating Income 2023–2026

Name: Colgate-Palmolive (India) Limited (COLPAL) operating income history 2023-2026
Creator: TickerBase
License: https://creativecommons.org/licenses/by/4.0/

DATA UPDATED 2026-09-20

Colgate-Palmolive (India) Limited annual operating income for fiscal 2026 was ₹17.3 billion, a decrease of 4.0% from ₹18.0 billion in fiscal 2025. All figures are reported results from public filings — no estimates or projections.

COLPAL Annual Operating Income

Operating Income (annual)	2026-03-31	2025-03-31	2024-03-31	2023-03-31
Operating Income (EBIT)	₹17.3B	₹18.0B	₹17.3B	₹13.7B

INR; ₹M / ₹B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

COLPAL Quarterly Operating Income

Operating Income (quarterly)	2026-06-30	2026-03-31	2025-12-31	2025-06-30	2025-03-31	2024-12-31
Operating Income (EBIT)	₹4.4B	₹4.7B	₹4.1B	₹4.2B	₹4.6B	—

INR; ₹M / ₹B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

Operating Income at Comparable Companies

MARICO Operating Income — Marico Limited
GODREJCP Operating Income — Godrej Consumer Products Limited
DABUR Operating Income — Dabur India Limited
4527 Operating Income — Rohto Pharmaceutical Co.,Ltd.
4912 Operating Income — Lion Corporation
4967 Operating Income — Kobayashi Pharmaceutical Co., Ltd.

More COLPAL metrics: Revenue · Gross Profit · Net Income · EPS · Free Cash Flow

All COLPAL financial statements → Interactive COLPAL charts →

About TickerBase · Data methodology & sources · Privacy · Terms

TickerBase is provided for educational and informational purposes only. It does not constitute financial, investment, tax, or legal advice, or a recommendation to buy, sell, or hold any security. No price targets are published; any per-share value shown in the valuation workbench is generated entirely from reader-supplied assumptions and is not the publisher's view of fair value. Past performance does not predict future results. Figures are approximate and drawn from public filings; one-time items are noted where identified. Do your own research and consult a licensed professional before making any investment decision. The author may or may not hold positions in the securities discussed.